This inventor holds 1 USPTO granted patent. Top assignee: Kissei Pharmaceutical Co., Ltd.. Active years: 1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995
Title: Ryoichi Yamagishi: Innovator in Indoline Compounds
Introduction
Ryoichi Yamagishi is a notable inventor based in Nagano, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on indoline compounds. His research focuses on developing therapeutic agents that address specific medical conditions.
Latest Patents
Yamagishi holds a patent for 1,5,7-trisubstituted indoline compounds and their salts. These compounds exhibit a selective suppressive action on urethral contractions, making them useful for treating dysuria with minimal hypotension, including postural hypotension. This patent highlights the potential of his work in improving patient care and treatment options.
Career Highlights
Yamagishi is associated with Kissei Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its innovative approach to addressing medical challenges through chemical compounds.
Collaborations
Yamagishi has collaborated with notable colleagues, including Makio Kitazawa and Kosuke Okazaki. These partnerships have contributed to the advancement of his research and the development of new therapeutic solutions.
Conclusion
Ryoichi Yamagishi's contributions to the field of pharmaceuticals through his innovative indoline compounds demonstrate his commitment to improving healthcare. His work continues to pave the way for new treatments that can enhance the quality of life for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile